ArticleClinical and experimental medicine2025

Venetoclax-based low-intensity chemotherapy in the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia.

Fangfei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.